NFE2L2, a well-established regulator of oxidative stress responses and xenobiotic detoxification, previously implicated in chemoresistance across multiple cancer types,50,51,52,53,54,55 emerged as a central hub. The gene discussed is NFE2L2; the disease is cancer.